Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent

被引:28
作者
Aubert-Pouëssel, A
Venier-Julienne, MC
Saulnier, P
Sergent, M
Benoît, JP
机构
[1] IBT, INSERM, U646, F-49100 Angers, France
[2] Univ Aix Marseille 3, Lab Methodol Rech Expt, F-13397 Marseille 20, France
关键词
diffusion process; glycofurol; microparticles; poly-(lactic-co-glycolic acid); protein;
D O I
10.1007/s11095-004-7693-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To develop biodegradable poly(lactic-co-glycolic acid) (PLGA) microparticles prepared by an original emulsion-extraction process, with glycofurol, a nontoxic excipient, as polymer solvent. Methods. The preparation of microparticles consisted in dissolving polymer in glycofurol. This solution was emulsified in a vegetable oil, and then amphiphilic agent was added into the emulsion to extract glycofurol and lead to microparticle formation. Physicochemical studies were carried out, and an experimental design was prepared in order to elucidate the impact of the formulation composition on the microparticle characteristics. Finally, encapsulation tests were made with a model protein. Results. In a ternary diagram, a small feasibility area allowing particle formation was located. The resulting microparticles were spherical with a homogeneous, polymeric matrix structure. They exhibited a variable size from 3 to 15 mum, which was controlled by the different formulation parameters. Differential scanning calorimetry (DSC) analysis made it possible to detect their composition. Preliminary results showed that these particles were able to encapsulate a protein model, lysozyme. Conclusions. This simple and convenient technique enabled us to obtain spherical, biodegradable microparticles from acceptable excipients. Moreover, the process conditions made possible the encapsulation of drugs, including proteins.
引用
收藏
页码:2384 / 2391
页数:8
相关论文
共 24 条
[1]  
AUBERTPOUESSEL A, 2003, Patent No. 03043605
[2]  
BENOIT JP, 1999, Patent No. 2797784
[3]  
COX DR, 1971, BIOMETRIKA, V58, P155, DOI 10.1093/biomet/58.1.155
[4]  
Crowther M. A., 1997, Human and Experimental Toxicology, V16, P406
[5]  
Eliaz R, 1996, CRS BUI NAT, P841
[6]  
Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.3.CO
[7]  
2-6
[8]   Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants:: In-vivo [J].
Eliaz, RE ;
Wallach, D ;
Kost, J .
PHARMACEUTICAL RESEARCH, 2000, 17 (12) :1546-1550
[9]   CONTROLLED-RELEASE OF CONTRACEPTIVE STEROIDS FROM BIODEGRADABLE AND INJECTABLE GEL FORMULATIONS - IN-VIVO EVALUATION [J].
GAO, ZH ;
CROWLEY, WR ;
SHUKLA, AJ ;
JOHNSON, JR ;
REGER, JF .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :864-868
[10]   Biological activity of lysozyme after entrapment in poly (d,l-lactide-co-glycolide)-microspheres [J].
Ghaderi, R ;
Carlfors, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1556-1562